Daily Newsletter

10 October 2023

Daily Newsletter

10 October 2023

DePuy Synthes gains FDA 510(k) clearance for thoracolumbar implant system

Johnson & Johnson Medtech’s orthopaedics division DePuy Synthes has secured FDA 510(k) clearance for its TriATLIS Spine System and Navigation Enabled Instruments.

Kiays Khalil October 10 2023

DePuy Synthes a Johnson & Johnson orthopaedics company has been awarded US Food and Drug Administration (FDA) 510(k) clearance for its thoracolumbar implant system, TriATLIS Spine System, and its Navigation Enabled Instruments.

The TriATLIS Spine System is a thoracolumbar pedicle screw system with a portfolio of instruments compatible with DePuy Synthes’ enabling technologies. It is designed to assist surgeons treating spinal issues such as inclusive of degenerative, tumour, trauma, and deformity pathologies. 

DePuy Synthes claims spinal deformity diseases affects 32% of young adults and 68% of adults over the age of 65. And with an ageing populations surgeons are seeing a wider scope of deformities that require spinal fusion instruments.

Daniel Sciubba Professor of Neurosurgery at Northwell Health/Hofstra praised the portfolio of implants from TriATLIS he said: “When it comes to treating complex spinal pathologies, each patient is different, and each case requires its own unique treatment decisions.”

Following the clearance, the TriATLIS Spine System will be available for the US market in 2024.

According to GlobalData, the surgical sutures market is growing at 3.4% annually to be worth $4.5 billion by 2033, up from a value of $3 billion in 2022.

In August DePuy Synthes secured FDA 510(k) Clearance for its INHANCE Shoulder System and 510(k) Clearance for MAXFRAME Multi-Axial Correction System.

Healthcare companies are hesitant to invest in the metaverse

Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close